Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Boston Scientific Delivers Q2 Sales Growth Across Its Product Lines

Jul 25 2019

• By Christopher Delporte

Boston Scientific Headquarters in Marlborough, MA — Boston Scientific's headquarters in Marlborough, MA (Warren Patterson)

Related Content

Boston Scientific Buys Vertiflex For $465M To Add Minimally Invasive Lumbar Procedure

May 09 2019

Long-Term Analysis Shows Boston Scientific’s Watchman Device Saves Money

Jul 04 2019

Despite Paclitaxel Warnings, Physicians Endorse Boston Sci’s Eluvia Stent For NTAP In CMS Pay Proposal Comments

Jul 10 2019

Panelists Grapple With Unclear Data At Paclitaxel Meeting

Jun 21 2019

Varian Grows Cancer Portfolio With Endocare & Alicon Acquisitions

Jun 12 2019

FDA Yanks Transvaginal Mesh From US Market; Boston Sci 'Surprised'; Firms Have 10 Days To Submit Withdraw Plan

Apr 16 2019

Boston Scientific Becomes Third US TAVR Competitor With Lotus Edge Approval

Apr 24 2019

Additional Topics

Companies Sales & Earnings Commercial Cardiovascular Cardiology Gynecology & Urology Medical Device

More from Cardiology

More from Device Area

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.